When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MNTA - Momenta's nipocalimab shows positive action in neuromuscular disorder
Momenta Pharmaceuticals Inc.
Momenta Pharmaceuticals (MNTA+0.9%) announces positive topline results from a proof-of-concept Phase 2 clinical trial, Vivacity-MG, evaluating nipocalimab (formerly M281) in patients with generalized myasthenia gravis (MG), a disorder characterized by weakness and rapid fatigue of skeletal muscles caused by disrupted communication between nerves and muscles.
More news on: Momenta Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,